EUVIMEDEUVIMED entdecken
Crossref

Therapeutic potential of 7-hydroxyflavone in letrozole-induced polycystic ovarian syndrome via regulation of oxidative stress, inflammation, hormonal and biochemical dysregulation

Ashish Tale, Deepak Lokwani, Komal Mandade, Sachin Borikar, Sangameshwar Kanthale, Satish Shelke, Shirish Jain

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-03 · 399 (6) · 9063-9079

DOI: 10.1007/s00210-026-04975-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 19.01.2026. Verfasst von Ashish Tale und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Rajarshi Shahu College of Pharmacy, Buldana, 443001, Maharashtra, India. Hauptthemen laut MEDLINE: Flavonoids, Polycystic Ovary Syndrome, Anti-Inflammatory Agents, Antioxidants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common gynaecological and endocrinological disorder that causes anovulatory infertility affecting 4-10% of women of reproductive age. Although current therapeutic options exist, many are accompanied by adverse effects, underscoring the need for safer and more effective alternatives. 7-Hydroxyflavone (7-HF), a natural flavonoid, has demonstrated notable biological properties; however, its therapeutic potential in PCOS remains unexplored. The current study aimed to explore the possible role of 7-HF in treating letrozole-induced PCOS in rats. METHODS: PCOS was induced in Female Wistar Rats by the administration of letrozole (1 mg/kg, p.o.) for 21 days. After induction, rats were treated with 7-Hydroxyflavone at various doses (5, 10 and 15 mg/kg) and metformin (300 mg/kg) for 14 consecutive days. RESULT: Letrozole-induced PCOS was characterized by disrupted estrous cycle, increased body and ovarian weights, cystic ovarian follicles, altered metabolic and hormonal levels, enhanced oxidative stress (elevated LPO, SOD; reduced GSH), and elevated inflammatory markers (TNF-alpha and IL-6). Treatment with 7-Hydroxyflavone significantly mitigated these alterations, restored normal estrous cycles and hormonal balance, reduced oxidative stress and inflammation, and improved ovarian histology in a dose-dependent manner. CONCLUSION: This study provides the first evidence that 7-Hydroxyflavone effectively mitigates letrozole-induced PCOS manifestations in rats, likely through its antioxidant, anti-inflammatory, and endocrine-modulating effects. These findings support the therapeutic potential of 7-HF as a novel candidate for PCOS management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsPolycystic Ovary SyndromeAnti-Inflammatory AgentsAntioxidantsOxidative StressInflammationLetrozoleAromatase InhibitorsHumansFemaleAnimalsRatsRats, WistarDisease Models, AnimalOvaryEstrous CycleDose-Response Relationship, Drug

Stichwörter der Autor:innen

7- Hydroxyflavone (7-HF)Estrus Cycle (EC)LetrozoleMetforminPolycystic Ovarian Syndrome (PCOS)

Substanzen

7-hydroxyflavoneFlavonoidsLetrozoleAnti-Inflammatory AgentsAntioxidantsAromatase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacology, Rajarshi Shahu College of Pharmacy, Buldana, 443001, Maharashtra, India.
  • Department of Pharmaceutical Chemistry, Rajarshi Shahu College of Pharmacy, Malvihir, Botha Road, Buldana, 443001, Maharashtra, India. dklokwani@gmail.com.
  • Department of Pharmaceutics, Rajarshi Shahu College of Pharmacy, Buldana, 443001, Maharashtra, India.
  • Department of Quality Assurance, Rajarshi Shahu College of Pharmacy, Buldana, 443001, Maharashtra, India.

Zitieren

APA

Tale, A., Lokwani, D., Mandade, K., Borikar, S., Kanthale, S., Shelke, S., & Jain, S. (2026). Therapeutic potential of 7-hydroxyflavone in letrozole-induced polycystic ovarian syndrome via regulation of oxidative stress, inflammation, hormonal and biochemical dysregulation. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(6), 9063-9079. https://doi.org/10.1007/s00210-026-04975-w

Vancouver

Tale A, Lokwani D, Mandade K, Borikar S, Kanthale S, Shelke S, et al. Therapeutic potential of 7-hydroxyflavone in letrozole-induced polycystic ovarian syndrome via regulation of oxidative stress, inflammation, hormonal and biochemical dysregulation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(6):9063-9079. doi:10.1007/s00210-026-04975-w

BibTeX
@article{Tale2026,
  author = {Tale, Ashish and Lokwani, Deepak and Mandade, Komal and Borikar, Sachin and Kanthale, Sangameshwar and Shelke, Satish and Jain, Shirish},
  title = {Therapeutic potential of 7-hydroxyflavone in letrozole-induced polycystic ovarian syndrome via regulation of oxidative stress, inflammation, hormonal and biochemical dysregulation},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {6},
  pages = {9063--9079},
  doi = {10.1007/s00210-026-04975-w}
}
Kostenlos starten →